TITLE

MERIDIAN SIGNS ACT TO ACQUIRE BIOTRIN HOLDINGS PLC

PUB. DATE
July 2002
SOURCE
Worldwide Biotech;Jul2002, Vol. 14 Issue 7, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on a letter of intent executed by Meridian Bioscience Inc. to acquire the outstanding capital stock of Biotrin Holdings PLC.
ACCESSION #
6939460

 

Related Articles

  • ClearPath launches molecular assay for Group B Strep.  // Business Journal (Central New York);10/12/2012, Vol. 26 Issue 41, p3B 

    The article offers information on the new women's health molecularassay illumigene GBS, launched by the company ClearPath Diagnostics for the detection of Group B Streptococcus.

  • MERIDIAN DISTRIBUTES RAPID TEST FOR STOMACH ULCERS.  // Worldwide Biotech;Sep2002, Vol. 14 Issue 9, p4 

    Reports that Meridian Bioscience Inc. has begun the international distribution of its patent protected ImmunoCard Stat! HpSA rapid test for Helicobacter pylori bacteria, the primary cause of stomach ulcers.

  • MERIDIAN/THERMO ELECTRON SIGN INFECTIOUS DISEASE TEST PACTS.  // Biotech Business;Dec2001, Vol. 14 Issue 12, p8 

    Reports on the agreements signed by Meridian Bioscience, Inc. for the distribution of infectious disease test with Thermo Electron Corp.

  • Product Briefs.  // Biomedical Business & Technology;Mar2009, Vol. 32 Issue 3, p30 

    The article evaluates the Premier Campy, a U.S. Food and Drug Administration (FDA)-approved test for Camplylobacter from Meridian Bioscience.

  • Manufacturer's Recall of Rapid Cartridge Assay Kits on the Basis of False-Positive Cryptosporidium Antigen Tests -- Colorado, 2004. Cronquist, A.; Beach, M. J.; Johnston, S. P.; Da Silva, A. // MMWR: Morbidity & Mortality Weekly Report;3/12/2004, Vol. 53 Issue 9, p198 

    Reports on the increase in cryptosporodiosis cases due to false-positive test results in Colorado during January-February 2004. Function of the Cryptosporidium/Giardia Rapid Assay developed by Meridian Bioscience Inc.; Background on the rapid testing conducted on cryptosporodiosis patients;...

  • Recapturing a Killer Flu Virus. Sieder, Jill Jordan; Campo-Flores, Arian // Newsweek;5/2/2005, Vol. 145 Issue 18, p36 

    Reports that Meridian Bioscience mistakenly began sending out more than 3,700 virus-test kits to labs throughout the US and 18 other countries in September 2004. How it was part of a routine quality-assurance program to ensure that such facilities are accurately identifying biological agents;...

  • Evaluation of a new rapid one step stool antigen test for Helicobacter pylori HP) infection diagnosis. Perna, F.; Tampieri, A.; Ricci, C.; Gatta, L.; Miglioli, M.; Vaira, D. // Gut;Sep2002 Supplement 2, Vol. 51, pA106 

    Premier Platinum HpSA, Meridian Bioscience Inc., Cincinnati, USA, has been proved highly accurate in diagnosing and monitoring the efficacy of HP treatment. A new rapid one-step lateral flow immunoassay, ImmunoCard STAT HpSA, has been introduced. Aim: To assess the accuracy of the new rapid test...

  • Vybion sells protein business to Ohio company. Tampone, Kevin // Business Journal (Central New York);7/18/2008, Vol. 22 Issue 29, p10B 

    The article reports on the acquisition of the recombinant protein business of Vybion Inc., a local biotechnology company by Meridian Bioscience Inc. in Ithaca, New York. The business which involves the production of proteins used in diagnostic medicine like blood testing was sold for $653,000....

  • Meridian gets Canadian license for illumigene.  // Medical Device Daily;10/1/2010, Vol. 14 Issue 191, p6 

    The article reports that Health Canada has issued a medical device license to Meridian Bioscience for its new molecular amplification assay, illumigene Clostridium dificile.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics